MedPath

Effect of erythropoietin on level of circulating endothelial progenitor cells and outcome in patients after acute ischaemic stroke

Completed
Conditions
Acute ischaemic stroke
Circulatory System
Stroke
Registration Number
ISRCTN71371114
Lead Sponsor
ational Science Council (Taiwan)
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
All
Target Recruitment
220
Inclusion Criteria

Patients aged greater than 45 years, either sex

Exclusion Criteria

Patients with history of the followings were excluded from the study:
1. Intracranial haemorrhage
2. Surgery or trauma within the preceding 3 months
3. Abnormal liver function
4. Haematology disorders
5. Renal insufficiency (serum creatinine greater than 1.5 mg/dL)
6. Malignancy
7. Febrile disorders
8. Acute or chronic inflammatory disease at study entry
9. Liver cirrhosis
10. Atrial fibrillation
11. Congestive heart failure
12. Contraindications for magnetic resonance imaging (MRI) examination
13. No evidence of acute IS by MRI study
14. Myeloproliferative disorder
15. Antibodies or being allergic to EPO
16. Pregnancy
17. Haemoglobin level greater than 15.0 g/d

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath